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Abstract 
The Sequence Ontology is undergoing reform to meet 
the standards of the OBO Foundry. Here we report 
some of the incremental changes and improvements 
made to SO. We also propose new relationships to 
better define the mereological, spatial and temporal 
aspects of biological sequence.  
 
Introduction 
The Sequence Ontology1 was begun in 2003 as a 
means to provide the terms and relations that obtain 
between terms, to describe biological sequence. The 
main purpose being the unification of the vocabulary 
used in genomic annotations, specifically genomic 
databases and flat file data exchange formats. 
Genomic data has been notoriously unspecified with 
a multitude of file formats expressing the same kind 
of data in different ways. Each gene prediction 
algorithm for example, exported the gene models in 
either a different format from other groups, or when 
they used the same format, the terms often had 
slightly different meanings.  Data integration between 
groups was therefore not straightforward. Likewise, 
validation of annotations relied on the programmers 
understanding the nuances of each kind of annotation 
and hard-coding their programs to match. The 
Sequence Ontology provides a forum for the genomic 
annotation community to discuss and agree on 
terminology to describe their biological sequence.  
 
The SO was initially divided into aspects to describe 
the features of biological sequence and the attributes 
of these features. A sequence feature is a region or a 
boundary of sequence that can be located in 
coordinates on biological sequence. SO uses a 
subsumption hierarchy to describe the kinds of 
features and meronomy to describe their containment. 
Features were related by their genomic position. For 
example polypeptides and transcripts are described 
by genomic context. This excluded their post-
genomic topology. 
 
The SO has a large user community of established 
model organism databases and newer ‘emerging 
model organism’ systems who rely on the GMOD2 
suite of tools to annotate and disseminate their 
genetic information. GMOD schemas and exchange 
formats rely on the SO to type their features such as 
the Chado database3, with its related XML formats 
and the tab delimited flat file exchange format 
GFF34. Several GMOD tools use GFF3, for example 
GBrowse5. SO is also used by genome integration 
projects such as Flymine6, modENCODE7 and the 
BRC pathogen data repository8. There are other uses 
for SO such as natural language processing initiatives 
that use the SO terminology9,10. 
 
The SO is one of the original members of the OBO 
Foundry11. The OBO ontology developers agreed to a 
set of shared principles for formal ontology design, 
with the aim of achieving orthogonal, interoperable 
ontologies. There are 10 principles for OBO Foundry 
membership which include a common syntax, a data-
versioning system, collaborative development, and 
adherence to the same set of defined relationships12. 
The OBO ontology developers attempt to accurately 
represent reality. Membership in the OBO Foundry 
represents a commitment to adhere to the ontology 
design principles and agree to reform where 
necessary. The OBO Foundry spans the biomedical 
domain in steps of granularity from the molecule to 
the population. It also encompasses the relations to 
time. Continuants endure through time, where as 
occurrents, which include processes, unfold through 
time in stages. The sequence features of SO are 
instantiated as molecules or parts of molecules. 
 
The SO has orthogonal neighbor ontologies within 
the OBO Foundry, also describing molecular 
continuants. Chemical entities of Biological Interest 
(ChEBI) is a dictionary of small chemical 
compounds13. It does not describe molecules encoded 
by the genome such as transcripts and peptides. The 
RNA Ontology14 describes the secondary and tertiary 
motifs of RNA as well as providing relationships 
between bases for base pairing and stacking. The 
Protein Ontology (PRO) defines the forms of proteins 
and the evolutionary relationships between protein 
families15. It is natural for these ontologies to interact 
and create inter-ontology terms in the form of cross 
products. To do so, the ontologies must all adhere to 
the same principles.  
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Coordinated reform of SO to OBO standards 
The SO, like other pre-exisiting ontologies has begun 
to undergo reform to meet the OBO Foundry 
standards.  
 
Textual Definitions 
New terms are now defined using OBO Foundry 
guidelines for definitions. The existing terms in SO 
were initially either defined by a member of the 
developer community, or via a cross reference to a 
reputable source. This has lead to inconsistency 
between the definitions, and sometimes inconsistency 
between the definition and placement of the term. 
The OBO Foundry recommends that terms be defined 
with respect to the is_a parent, and the attributes that 
differentiate the term from its parent and sibling 
terms, called the differentiae. This practice forces a 
self check on the whether the position of the term in 
the ontology agrees with the defined meaning of the 
term. New definitions in SO must adhere to the “A 
is_a B that C’s” principle. For example, the new 
term, vector_replicon, a subtype of replicon, has the 
following definition: A replicon that has been 
modified to act as a vector for foreign sequence. 
Existing terms are undergoing a refinement process.  
 
Logical Definitions 
In addition to providing text definitions, the SO 
includes over 100 ‘cross-product’ definitions in 
genus/differentiae form16. A reasoner can then be 
used to place the terms in the correct place in the 
ontology. This is especially useful as it untangles the 
graph for editing purposes. The SO is released in two 
forms, either with the logical definitions, or fully 
classified for use without a reasoner.  
 
Parthood Relations 
The SO must adhere to the principles of OBO 
Relations Ontology (RO). The RO provides a set of 
defined formal type level and instance level relations. 
The list of relations may be extended by individual 
ontologies as required. The class level relations 
follow the “ALL_SOME” rule17. This rule is 
necessary to improve the ability to reason over data 
that uses the ontology. In practice, making these 
changes to SO has required the addition of the 
‘has_part’ relation to the ontology. Prior to this 
change the SO stated that:  
TATA_box part_of RNApol_II_promoter and  
TATA_box part_of RNApol_III_promoter.  
This was incorrect as all TATA_boxes are not part of 
both kinds of promoter. The ontology now states that 
RNApol_III_promoter has_part TATA_box.  
The integral_part_of relation and its inverse have 
been added to clarify the occasions when the part and 
the whole must both exist. 
 
Temporal relations and spatial interval relations 
There are several kinds of relation that are needed to 
describe the complex nature of biological sequence. 
Mereological relations are needed to describe 
containment. Spatial relations are needed to relate the 
positional information about features. Each 
transformation of sequence requires a temporal 
relation. Finally as SO is part of a larger suite of 
ontologies, it will need relations with which to make 
cross products and refer to other ontologies. We 
propose to extend SO with the relations outlined in 
Table 1. 
 
Biological sequence is predominantly instantiated in 
three kinds of polymeric molecule: DNA, RNA and 
polypeptide, although man-made polymers such as 
PNA do exist. The SO will represent the 
transformation of sequence from one kind of 
molecule to another using the temporal relations 
shown in Table 1. A gene, manifest in DNA 
transcribed_into the primary_transcript, which is 
expressed as RNA. A polypeptide sequence is a 
translation_of the CDS sequence. Transcript 
molecules also undergo processing such as splicing 
and editing which remove or add additional 
sequences. The relations processed_from and 
processed_into relate the primary transcript to its 
mature processed  form. 
 
It is important to understand how the proposed 
changes will affect the annotation community who 
already use the terms and relations of SO in their 
pipelines and processes. This will effect how the 
changes are released. The terminology used to type 
the features already in use will not change. The GFF3 
format will be unaffected as it lists the feature types 
and the parent term of a given relation. It does not 
name the relation – this is maintained in the ontology.  
 
Developers will need to be given notice of new 
relationships and structures however, as this may 
have adverse effects of pipelines and programs.  
 
The proposed changes to the SO relationships and 
structure can be found on the SO website at following 
address: 
http://www.sequenceontology.org/resources/propose
d_relationships.html 
 
Conclusions 
The updates to the SO, based on OBO Foundry 
recommendations have strengthened the ontology as 
a tool for reasoning. The treatment of definitions 
enforces a tight regulation on the position of a new 
term in the ontology and synchronizes the textual  
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 Name  Definition example 
part_of X part_of Y if X is a subregion of Y. amino_acid part_of polypeptide 
has_part Inverse of part_of operon has_part gene 
integral_part_of X integral_part_of Y if and only if: X part_of Y and Y 
has_part X 
exon integral_part_of transcript 
M
er
eo
lo
gi
ca
l  
has_integral part X has_integral_part Y if and only if: X has_part Y and 
Y part_of X 
mRNA has_integral_part CDS 
transcribed_from X is transcribed_from Y if X is synthesized from 
template Y. 
primary_transcript transcribed_from gene 
transcribed_to Inverse of transcribed_from gene  transcribed_to primary_transcript  
translation_of X is translation of Y if X is translated by ribosome to 
create Y. 
Polypeptide translation_of CDS 
translates_to Inverse of translation _of codon translates_to amino_acid 
processed_from Inverse of processed_into miRNA processed_from 
miRNA_primary_transcript 
Te
m
po
ra
l  
processed_into X is processed_into Y if a region X is modified to create 
Y. 
miRNA_primary_transcript processed into 
miRNA 
contained_by X contained_by Y iff X starts after start of Y and X ends 
before end of Y 
intein contained_by 
immature_peptide_region 
contains Inverse of contained_by Pre-miRNA contains miRNA_loop 
overlaps X overlaps Y iff there exists some Z such that Z 
contained_by X and Z contained_by Y 
coding_exon overlaps CDS 
maximally_overlaps A maximally_overlaps X and Y iff all parts of A 
(including A itself) overlap both X and Y 
non_coding_region_of_exon maximally 
overlaps the intersection of exon and UTR 
connects_on X connects_on Y,Z,R iff whenever X is on a R, X is 
adjacent_to a Y and adjacent_to a Z 
splice_junction connects_on exon, exon 
mature_transcript 
disconnected_from X is disconnected_from Y iff it is not the case that X 
overlaps Y 
intron disconnected_from exon {on 
transcript} 
adjacent_to X adjacent to Y if and only if: X and Y share a boundary 
but do not overlap 
UTR adjacent_to CDS 
started_by X is started by Y, if Y is part_of X and X and Y share a 
5 prime boundary. 
CDS started_by start_codon 
finished_by X is finished by Y if Y is part_of X and X and Y share a 
3 prime boundary 
CDS finished_by stop_codon 
starts X starts Y is X is part of Y and X and Y share a 5 prime 
boundary. 
start_codon starts CDS 
finishes X finishes Y if X is part_of Y and X and Y share a 3' 
boundary. 
stop_codon finishes CDS 
Sp
at
ia
l I
nt
er
va
l is_consecutive_sequence_of R is_consecutive_sequence_of U if and only if every 
instance of R is equivalent to a collection of instances of 
U u1,u2,...,un such that no pair ux uy is overlapping, and 
for all ux, ux is adjacent_to ux-1 and ux+1, with the 
exception of the initial and terminal u1 and un (which 
may be identical). 
region is_consecutive_sequence_of base 
 
processed_transcript 
is_consective_sequence_of exon 
site_of A is a site of B if A is the sequence_feature of a 
molecule where a GO:biological process B occurs. 
CDS site_of RNA polymerase activity 
output_of A is an output_of B if A is a sequence_feature of a 
molecule that is produced by GO:biological process B. 
primary_transcript output_of transcription 
C
ro
ss
 
on
to
lo
gy
 
regulates_expression_of A regulates expression of B if A is a regulatory region 
that controls the expression of B, where B is a gene. 
regulatory_region regulates_expression_of 
gene 
Table 1. New relations proposed for SO. Definitions are for instance level relations, examples are for class-level 
relations, which follow from the instance-level definition in the standard all-some pattern.  
 
definition within the subsumption hierarchy. The 
process of updating all of the definitions is ongoing. 
Stricter adherence to the OBO Relations Ontology is 
making SO interoperable with the other OBO 
ontologies. The SO uses a reasoner to maintain the 
is_a parents of cross product terms. This aids 
ontology maintenance and can be used as a model for 
other OBO ontologies. 
 
The application of sequence features that span the 
range of the molecular biology central dogma, rather 
than simply the position of the genomic region that 
encodes the molecule, is a subtle but important step 
forward. It allows the topological relations at each 
stage from genome to transcript or peptide to be 
catalogued. It roots the SO within OBO making cross 
products between the sibling ontologies possible. 
 
The addition of a suite of mereological, topological 
and temporal relations will dramatically enhance the 
ability to use the SO as a tool for computational 
reasoning. Each of the new defined relationships adds 
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another avenue for analysis. This is especially 
important for the validation of sequence annotations 
using SO.  
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